Login to Your Account

Triphase streamlining early stage explorations for Celgene Corp.

By Michael Fitzhugh
Staff Writer

Tuesday, November 11, 2014
Triphase Accelerator Corp., a tiny drug developer with big backing from a Celgene Corp. deal, is pushing to bring economic rationality to the long haul between investigational new drug application filings and phase II proof of concept.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription